Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
Xinle Cui, Clifford M. Snapper
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125

Showing 26-50 of 125 citing articles:

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
Marija Rozman, Petra Korać, Karlo Jambrosic, et al.
Pathogens (2022) Vol. 11, Iss. 8, pp. 864-864
Open Access | Times Cited: 21
Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
Oren Shechter, Daniel Sausen, Elisa S. Gallo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14389-14389
Open Access | Times Cited: 19
Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation
Haiqi Tan, Yibing Gong, Yi Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114916-114916
Open Access | Times Cited: 11
The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale
Van-Trang Dinh, Nadège Loaëc, Alicia Quillévéré, et al.
Biochimie (2023) Vol. 214, pp. 57-68
Closed Access | Times Cited: 11
The intersection of virus infection and liver disease: A comprehensive review of pathogenesis, diagnosis, and treatment
Meng Ren, Chenxia Lu, Mingwei Zhou, et al.
WIREs Mechanisms of Disease (2024) Vol. 16, Iss. 3
Open Access | Times Cited: 4
Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development
Mahtab Mohammadzamani, Kimia Kazemzadeh, Swati Chand, et al.
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response
Patrick Naughton, F. Enright, Brigid Lucey
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 3, pp. 157-163
Closed Access | Times Cited: 4
Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena
Raed Obaid Saleh, Fatma M. Ibrahim, Harikumar Pallathadka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 4
Clinical, Epidemiological, Morphological, and Immunohistochemical Aspects of Nasopharyngeal Carcinoma—4-Year Retrospective Study in the Western Part of Romania
Maria Alina Marin, Raluca Maria Cloşca, Aurel Marin, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 722-722
Open Access | Times Cited: 4
Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 4
Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
Vivien Li, Fiona C. McKay, David C. Tscharke, et al.
CNS Drugs (2025)
Closed Access
Modern approaches to predicting vaccine hesitancy: A scoping review
Keshav Gandhi, Sami Alahmadi, Rosie Hanneke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
Qiaolin Huang, Xiaojian Zhu, Yicheng Zhang
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Anti-Epstein–Barr Virus Activities of Flavones and Flavonols with Effects on Virus-Related Cancers
Sherif T. S. Hassan
Molecules (2025) Vol. 30, Iss. 5, pp. 1058-1058
Open Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Case Report: Hydroa vacciniforme-like lymphoproliferative disorder, an EBV-associated disease, successfully treated with hematopoietic stem cell transplantation
Eduardo Liquidano-Pérez, Gibert Maza‐Ramos, Marco Antonio Yamazaki‐Nakashimada, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The use of peptides for deciphering the mechanism of EBV, HPV, and HCV invasion of human cells
Daniela Perdomo-Joven, Fanny Guzmán, Mauricio Urquiza
(2025)
Open Access
Paediatric autoimmune uveitis is associated with intraocular antibodies against Epstein–Barr virus Nuclear Antigen 1 (EBNA-1)
Jytte Hendrikse, Louis Bont, Peter A. W. J. F. Schellekens, et al.
EBioMedicine (2025) Vol. 115, pp. 105681-105681
Closed Access
A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection In Vitro and In Vivo
Ling Zhong, Wanlin Zhang, Rui Xiao, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Identification of key hub genes and potential therapeutic drugs for nasopharyngeal carcinoma: Insights into molecular mechanisms and treatment strategies
Haiyan Quan, Huachun Yin, Zhen Wang, et al.
Brazilian Journal of Otorhinolaryngology (2025) Vol. 91, Iss. 4, pp. 101618-101618
Closed Access
Identification of B cell antigens in solid cancer: initial insights and functional implications
Jung‐In Yang, Philip Moresco, Douglas T. Fearon, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma
Weiwei Zhang, CHUN‐JIE WANG, Yousheng Meng, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 478-478
Open Access
Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods
Lin Zhang, Rui Mao, Chung Tai Lau, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Post‐transplant lymphoproliferative disease in children, adolescents, and young adults
Thomas G. Gross, Jeremy D. Rubinstein
Hematological Oncology (2023) Vol. 41, Iss. S1, pp. 48-56
Open Access | Times Cited: 9
EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management
Luis Malpica, Mario L. Marques‐Piubelli, Brady Beltrán, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 10, pp. 2002-2015
Closed Access | Times Cited: 3

Scroll to top